Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
20+ Year Trsy Bond Ishares | TLT | Nov 27, 2024 | 93.01 | +0.69 |
20+ Year Trsy Bull 3X Direxion | TMF | Nov 27, 2024 | 48.62 | +2.06 |
22nd Century Group | XXII | Nov 27, 2024 | 0.10 | -4.52 |
23andMe | ME | Nov 27, 2024 | 3.14 | -0.63 |
25+ Year Zero Cpn U.S. Trsy Idx ETF Pimco | ZROZ | Nov 27, 2024 | 76.22 | +0.95 |
2seventy bio | TSVT | Nov 27, 2024 | 3.96 | +7.32 |
3-7 Year Treasury Bond Ishares | IEI | Nov 27, 2024 | 116.86 | +0.26 |
30 Year Tips/Tsy Spread Proshares | RINF | Nov 27, 2024 | 32.84 | +0.15 |
36Kr ADR | KRKR | Nov 27, 2024 | 3.00 | -1.32 |
374Water | SCWO | Nov 27, 2024 | 1.00 | -3.37 |
3D Systems | DDD | Nov 27, 2024 | 2.95 | -13.49 |
3M | MMM | Nov 27, 2024 | 132.48 | -0.35 |
4D Molecular Therapeutics | FDMT | Nov 27, 2024 | 7.87 | +4.93 |
51Talk Online Education Group ADR | COE | Nov 27, 2024 | 14.50 | -0.34 |
5E Advanced Materials | FEAM | Nov 27, 2024 | 0.46 | -0.07 |
60 Degrees Pharmaceuticals | SXTP | Nov 27, 2024 | 1.09 | +7.92 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Nov 27, 2024 | 13.93 | -1.26 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Nov 27, 2024 | 25.31 | +1.08 |
7-10 Yr Trsy Ishares | IEF | Nov 27, 2024 | 94.79 | +0.40 |
89bio | ETNB | Nov 27, 2024 | 9.14 | +2.70 |
8x8 | EGHT | Nov 27, 2024 | 3.14 | -0.63 |
908 Devices | MASS | Nov 27, 2024 | 2.62 | +1.16 |
99 Acquisition Group | NNAGU | Nov 27, 2024 | 10.60 | 0.00 |
9F ADR | JFU | Nov 27, 2024 | 1.36 | -10.52 |
A SPAC II Acquisition | ASCB | Nov 27, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Nov 27, 2024 | 30.48 | +2.04 |
a.k.a Brands | AKA | Nov 27, 2024 | 21.36 | +1.96 |
A.O Smith | AOS | Nov 27, 2024 | 74.10 | +0.27 |
A10 Networks | ATEN | Nov 27, 2024 | 17.13 | +1.12 |
A2Z Cust2Mate Solutions | AZ | Nov 27, 2024 | 6.69 | +0.75 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.